Fosun Pharmaceutical: the subsidiary plans to invest 10 million yuan to participate in the establishment of the target fund
Financial Associated Press, Dec. 28 - Fosun Pharmaceutical announced that Ningbo Fuying, the company's holding subsidiary, and Sinopharm CICC plan to jointly contribute to the establishment of a target fund, which is specially used for the investment in Chenxi health. The target fund plans to raise 11.11 million yuan, of which Ningbo Fuying (as LP) and Sinopharm Zhongjin (as GP) plan to contribute 10 million yuan and 1.11 million yuan in cash to subscribe for the equivalent property shares of the target fund.
This text is a result of machine translation.
Related companies：
Briefing Jun 25, 2022 06:50 AM
In the half year, the 36billion yuan production expansion plan has been thrown away, and the competition in the stock market of Baijiu is fierce
In-depth
Healthcare
Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
Jun 27, 2022 05:00 PM
May 02, 2022 07:50 PM
Apr 26, 2022 12:26 PM
Apr 25, 2022 01:02 PM
Briefing Jun 24, 2022 10:29 AM
· Consumer Staples
Dongbei group: the holding foundry subsidiary currently produces brake discs and other products at full capacity, with orders in short supply
Healthcare, Financials
Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps
Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.
Apr 27, 2022 10:55 PM
Tianci materials: it is planned to buy back the company's shares of RMB 250million to RMB 500million
See more
Read next
In-depth
In-depth
In-depth
Technology
A Closer Look at China’s Cloud Service Market, Guessing Who Will Succeed? [1/2]
Jun 27, 2022 05:09 PM
In-depth
Healthcare
Exclusive Interview with Xu Qian, Managing Partner of Redhill Capital
Jun 27, 2022 12:24 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.